India among 20 countries interested in obtaining Covid-19 vaccine from Russia
RDIF has seen strong global interest in the vaccine and plans to conduct Phase 3 clinical trials in different countries, including Saudi Arabia, UAE, Brazil, India and Philippines, and start mass production in other countries in partnership with local sovereign wealth funds, including India, (...)
Site référencé: The Economic Times
The Economic Times
These equity MFs failed to outperform their benchmarks in three years
1er/05/2024
Tata Comm taking sustainable route for $1 billion fundraising goal
1er/05/2024
Capacity addition, cost initiatives to help UltraTech retain its edge
1er/05/2024
G7 agrees to phase out coal-fired power plants by mid-2030s
30/04/2024
Tech View : Nifty forms Shooting Star candle. What should traders do on Thursday
30/04/2024
Manappuram Finance shares rally 5% on Sebi nod to IPO of subsidiary Asirvad Micro Finance
30/04/2024
